Department of Pediatric Dentistry, Faculty of Dentistry, Tishreen University, Lattakia, Syria.
Eur Arch Paediatr Dent. 2023 Oct;24(5):621-630. doi: 10.1007/s40368-023-00827-w. Epub 2023 Aug 1.
The current study compares articaine 4% with lidocaine 2% in terms of injection pain and effectiveness of anesthesia when treating permanent mandibular first molars (PMFMs) affected by molar incisor hypomineralization (MIH). In addition to comparing the complications of local anesthesia for both solutions.
The sample included 20 children. Each child was randomly assigned to either articaine 4% or lidocaine 2% in their first session with the other solution being used at the subsequent session. Injection pain and the effectiveness of anesthesia were assessed using the Wong-Baker Faces® Pain Rating Scale and the Face, Legs, Activity, Cry, and Consolability (FLACC) scale. Parents were asked to report any complications of local anesthesia. The Wilcoxon-matched pairs signed-rank test was used to analyze the data.
Patients experienced greater pain when receiving articaine 4% injections according to both scales, differences were statistically significant when using the Wong-Baker Faces® Pain Rating scale (p < 0.05). Whereas, the FLACC scale did not show such differences (P > 0.05). Although there were no significant differences between the two solutions regarding the effectiveness of local anesthesia according to both scales (P > 0.05), articaine 4% was clinically found to be more effective than lidocaine 2%. No complications of local anesthesia were reported.
Articaine 4% injection was more painful than lidocaine 2%. However, both solutions were effective in anesthetizing PMFMs affected by MIH and without anesthetic complications in the studied sample.
Clinical trial, NCT05200884, ( https://clinicaltrials.gov/ct2/show/NCT05200884 ).
本研究比较了 4%阿替卡因和 2%利多卡因在治疗受低矿化磨牙症(MIH)影响的下颌第一恒磨牙(PMFMs)时的注射疼痛和麻醉效果。此外,还比较了两种溶液局部麻醉的并发症。
该样本包括 20 名儿童。每个孩子在第一次就诊时随机分配接受 4%阿替卡因或 2%利多卡因注射,随后的就诊中则使用另一种溶液。使用 Wong-Baker Faces®疼痛评定量表和面部、腿部、活动、哭泣和安慰(FLACC)量表评估注射疼痛和麻醉效果。家长被要求报告局部麻醉的任何并发症。采用 Wilcoxon 配对符号秩检验对数据进行分析。
根据两种量表,患者在接受 4%阿替卡因注射时都感到更疼痛,Wong-Baker Faces®疼痛评定量表的差异具有统计学意义(p<0.05)。然而,FLACC 量表并未显示出这种差异(P>0.05)。根据两种量表,两种溶液在局部麻醉效果方面均无显著差异(P>0.05),但临床发现 4%阿替卡因比 2%利多卡因更有效。未报告局部麻醉的并发症。
4%阿替卡因注射比 2%利多卡因更痛。然而,在研究样本中,两种溶液均能有效麻醉受 MIH 影响的 PMFMs,且无麻醉并发症。
临床试验,NCT05200884(https://clinicaltrials.gov/ct2/show/NCT05200884)。